The case {#S1}
========

A 31-year-old woman (Figure [1](#F1){ref-type="fig"}: III-1) was evaluated for mild renal failure. The serum creatinine was 1.5 mg/dL and the creatinine clearance 55 mL/min (Cockcroft formula). The blood urea nitrogen and urate levels were 52 and 4.8 mg/dL, respectively. There was a mild microalbuminuria (57 mg/24 h); urinalysis was unremarkable. Renal ultrasonography showed a right kidney of 9.5 cm and a left kidney of 9.2 cm, with normal echogenicity and no cysts; Doppler examination was normal.

![Pedigree of the family. Individuals with renal failure are depicted by black symbols. Circles denote females, squares males.](sfp068fig1){#F1}

The patient\'s father (II-2) had a 20-year history of slowly progressive renal failure of unknown origin, leading to dialysis initiation at age 58. A CT scan revealed the existence of small kidneys with several cysts. One month before starting dialysis, he underwent unilateral nephrectomy for renal cell carcinoma. He had suffered a few attacks of gout starting at age 55. The father has one brother (II-4), apparently healthy. The paternal grandfather of the proband (I-1) died at age 60 of uraemia, after a history of gout and heart disease.

Question {#S1-1}
--------

What is your clinical diagnosis? What genetic abnormality do you suspect?

Answer {#S1-2}
------

The diagnosis is chronic interstitial nephritis caused by a mutation in the *UMOD* gene.

Discussion {#S2}
==========

Based on urinalysis, the mild chronic renal failure in this young patient was most likely attributed to a chronic interstitial nephritis. The family history was highly suggestive of a hereditary disorder, with a male-to-male transmission testifying to an autosomal-dominant trait (Figure [1](#F1){ref-type="fig"}). The history of gout in both father and grandfather, though of late occurrence, was compatible with a diagnosis of familial juvenile hyperuricaemic nephropathy (FJHN/MCKD2). The most frequent cause of this disorder is a mutation in *UMOD*, the gene coding for uromodulin (Tamm--Horsfall protein) \[[@R1]\]. Genetic analysis in this family identified a missense mutation (Cys170Tyr) in the exon 4 of *UMOD* (Figure [2](#F2){ref-type="fig"}). This change is predicted to cause misfolding of the protein by removal of a disulfide bridge, leading to abnormal accumulation of mutated uromodulin within tubular cells, and subsequent tubular dysfunction, interstitial fibrosis and slowly progressive renal failure \[[@R1]\]. These features were indeed observed in the nephrectomy specimen from the father (Figure [3](#F3){ref-type="fig"}), which showed areas of tubulo-interstitial atrophy with cysts at the cortico-medullary junction. Of note, the proband showed a typical decrease in the urinary excretion of uromodulin (1.1 mg/g creat, for a normal mean value of 9.4 ± 0.33 mg/g creat).

![Mutation of *UMOD*. Sequence analysis of the *UMOD* gene revealed a guanine to adenine transition at nucleotide 510 (c.510G\>A) in the exon 4 resulting in the substitution of a highly conserved cysteine by a tyrosine at position 170 (p.Cys170Tyr). This mutation is located in the cysteine-rich domain of the 640 amino-acid uromodulin \[[@R1]\]. Encoded amino acid sequence is indicated above the DNA sequence. Mutated nucleotide is boxed.](sfp068fig2){#F2}

![Pathology features and uromodulin accumulation in mutated kidney. (**A**) Examination of the nephrectomy specimen obtained in the father revealed small cortical and cortico-medullary cysts of which one is large (^\*^) and mainly located in the medulla (Haemalum--eosine). Insert: dilation and duplications of tubular basement membranes of preserved and atrophic cortical tubules, respectively (PAS staining). (**B**) and (**C**) Intense immunostaining for uromodulin was detected in a subset of tubule profiles that were enlarged or cystic. At higher magnification (**C**) the staining for uromodulin is intense and diffusely intracellular. Immunostaining was performed as detailed in \[[@R1]\]. Original magnifications: 10× (**A**); 160× (**B**) and ×320× (**C**).](sfp068fig3){#F3}

The earliest common manifestation of FJHN is hyperuricaemia caused by increased tubular reabsorption of urate \[[@R3]\]. However, our patient had a serum urate level only in the high-normal range, with a fractional excretion of urate measured twice at 8% and 10%, for a normal value of 12.8 ± 2.9% in females \[[@R4]\]. A recent study in a large number of affected relatives carrying another *UMOD* mutation revealed that hyperuricaemia was lacking in 8% of them, with affected female patients showing a serum urate level ≤6 mg/dL despite a mild decrease in the fractional excretion of urate \[[@R4]\]. Further studies in young patients with various *UMOD* mutations should better delineate the range of serum uric acid levels in this disorder.

In summary, the family history provided the crucial clue to the diagnosis of FJHN caused by a mutation in *UMOD*. In a young patient with a picture of chronic interstitial nephritis, even with a normal serum uric acid level, a family history of chronic interstitial nephritis compatible with an autosomal-dominant transmission should evoke this diagnosis, particularly when hyperuricaemia and/or gout is documented in other family members. Establishing the diagnosis of FJHN is relevant for genetic counselling and advising for kidney transplantation \[[@R5]\].
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